# Stock Analysis Test Results

**Test Date**: 2025. 12. 5. 오후 3:56:54
**Total Stocks**: 19
- NASDAQ: 9
- NYSE: 10

---

## AMZN

### Phase 2: Combined Data

**Ticker**: AMZN
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $229.11
- Market Cap: $2449.24B
- 52W High: $258.60
- 52W Low: $161.38
- 200D MA: $214.75
- TTM PER: 32.31

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | -0.27 | -1.9% | 0.0 | 11.2 | 3.2 | 50.44 | $9.2B |
| 2023 | 2.90 | 17.5% | 81.8 | 12.2 | 4.3 | 54.78 | $35.1B |
| 2024 | 5.52 | 24.3% | 42.3 | 8.6 | 3.9 | 59.51 | $21.5B |


### Phase 3: Investment Analysis

**Ticker**: AMZN
**Current Price**: $229.11
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: N/A
- **Logic**: Invalid EPS data for growth calculation

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: N/A
- **Logic**: Negative EPS in period - cannot calculate growth rate

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $57.90
- **Graham Number**: $57.90
- **Logic**: EPS 5.52, BPS 26.99 → Graham # $57.90

#### Ken Fisher (Sales-Based)
- **Verdict**: HOLD
- **Target Price**: $227.33
- **Sell Price**: $258.87
- **Logic**: PSR 3.91 vs avg 3.82 → buy target $227.33, max PSR 4.35 → sell at $258.87

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: HOLD
- **Exit Condition**: Exit if price falls below 200-day MA ($214.75)
- **Logic**: Price above 200-day MA but pulled back from 52-week high - trend intact but momentum weak

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 69.7% of 52-week range (mid-cycle) - neutral positioning



---

## AVGO

### Phase 2: Combined Data

**Ticker**: AVGO
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $381.03
- Market Cap: $1799.36B
- 52W High: $403.00
- 52W Low: $138.10
- 200D MA: $273.65
- TTM PER: 98.20

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 26.67 | 34.6% | 34.9 | 17.1 | 11.6 | 78.49 | $16.1B |
| 2023 | 3.35 | 60.3% | 53.6 | 31.0 | 23.4 | 8.39 | $17.4B |
| 2024 | 1.52 | 13.5% | 264.5 | 27.9 | 36.9 | 10.79 | $-3.1B |


### Phase 3: Investment Analysis

**Ticker**: AVGO
**Current Price**: $381.03
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: SELL
- **Target Price**: $0.00
- **Logic**: ROE 36.13%, Growth -76.1% → compounding -114.2%, PER 117.6x → 10yr target $0.00, discounted to $0.00 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: N/A
- **Logic**: Growth rate -76.1% too low for Lynch model (minimum 5%)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $22.20
- **Graham Number**: $22.20
- **Logic**: EPS 1.52, BPS 14.41 → Graham # $22.20

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $258.49
- **Sell Price**: $398.15
- **Logic**: PSR 36.90 vs avg 23.96 → buy target $258.49, max PSR 36.90 → sell at $398.15

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($273.65)
- **Logic**: Price $381.03 above 200-day MA ($273.65) and near 52-week high ($403.00) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($381.03)
- **Logic**: Price at 91.7% of 52-week range (top) - cycle top risk, consider taking profits



---

## GOOGL

### Phase 2: Combined Data

**Ticker**: GOOGL
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $317.62
- Market Cap: $3847.05B
- 52W High: $328.83
- 52W Low: $140.53
- 200D MA: $204.02
- TTM PER: 31.35

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 4.56 | 23.6% | 33.4 | 7.6 | 6.8 | 21.49 | $71.2B |
| 2023 | 6.24 | 28.1% | 32.7 | 9.0 | 8.2 | 24.16 | $74.7B |
| 2024 | 8.39 | 33.8% | 38.2 | 12.0 | 11.0 | 28.12 | $79.8B |


### Phase 3: Investment Analysis

**Ticker**: GOOGL
**Current Price**: $317.62
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $885.96
- **Logic**: ROE 28.52%, Growth 35.6% → compounding 28.5%, PER 34.8x → 10yr target $3584.22, discounted to $885.96 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: BUY
- **Target Price**: $299.05
- **PEG Ratio**: 0.88
- **Logic**: EPS growth 35.6% CAGR, PER 31.35 → PEG 0.88

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $70.90
- **Graham Number**: $70.90
- **Logic**: EPS 8.39, BPS 26.63 → Graham # $70.90

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $243.33
- **Sell Price**: $310.44
- **Logic**: PSR 11.04 vs avg 8.65 → buy target $243.33, max PSR 11.04 → sell at $310.44

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($204.02)
- **Logic**: Price $317.62 above 200-day MA ($204.02) and near 52-week high ($328.83) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($317.62)
- **Logic**: Price at 94.0% of 52-week range (top) - cycle top risk, consider taking profits



---

## GOOG

### Phase 2: Combined Data

**Ticker**: GOOG
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $318.39
- Market Cap: $3843.55B
- 52W High: $328.67
- 52W Low: $142.66
- 200D MA: $205.16
- TTM PER: 31.43

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 4.56 | 23.6% | 33.4 | 7.6 | 6.8 | 21.49 | $71.2B |
| 2023 | 6.24 | 28.1% | 32.7 | 9.0 | 8.2 | 24.16 | $74.7B |
| 2024 | 8.39 | 33.8% | 38.2 | 12.0 | 11.0 | 28.12 | $79.8B |


### Phase 3: Investment Analysis

**Ticker**: GOOG
**Current Price**: $318.39
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $885.96
- **Logic**: ROE 28.52%, Growth 35.6% → compounding 28.5%, PER 34.8x → 10yr target $3584.22, discounted to $885.96 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: BUY
- **Target Price**: $299.05
- **PEG Ratio**: 0.88
- **Logic**: EPS growth 35.6% CAGR, PER 31.43 → PEG 0.88

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $70.90
- **Graham Number**: $70.90
- **Logic**: EPS 8.39, BPS 26.63 → Graham # $70.90

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $243.33
- **Sell Price**: $310.44
- **Logic**: PSR 11.04 vs avg 8.65 → buy target $243.33, max PSR 11.04 → sell at $310.44

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($205.16)
- **Logic**: Price $318.39 above 200-day MA ($205.16) and near 52-week high ($328.67) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($318.39)
- **Logic**: Price at 94.5% of 52-week range (top) - cycle top risk, consider taking profits



---

## META

### Phase 2: Combined Data

**Ticker**: META
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $661.53
- Market Cap: $1667.40B
- 52W High: $796.25
- 52W Low: $479.80
- 200D MA: $671.78
- TTM PER: 29.30

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 10.61 | 19.7% | 37.1 | 8.2 | 8.7 | 43.16 | $21.5B |
| 2023 | 16.19 | 28.4% | 40.0 | 10.8 | 12.1 | 51.31 | $46.6B |
| 2024 | 24.26 | 37.6% | 26.7 | 9.0 | 9.9 | 62.93 | $44.2B |


### Phase 3: Investment Analysis

**Ticker**: META
**Current Price**: $661.53
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $2564.08
- **Logic**: ROE 28.58%, Growth 51.2% → compounding 28.6%, PER 34.6x → 10yr target $10373.14, discounted to $2564.08 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: BUY
- **Target Price**: $1242.42
- **PEG Ratio**: 0.57
- **Logic**: EPS growth 51.2% CAGR, PER 29.30 → PEG 0.57

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $198.32
- **Graham Number**: $198.32
- **Logic**: EPS 24.26, BPS 72.05 → Graham # $198.32

#### Ken Fisher (Sales-Based)
- **Verdict**: BUY
- **Target Price**: $644.82
- **Sell Price**: $762.71
- **Logic**: PSR 9.93 vs avg 10.25 → buy target $644.82, max PSR 12.12 → sell at $762.71

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: SELL
- **Exit Condition**: Exit if price falls below 200-day MA ($671.78)
- **Logic**: Price $661.53 below 200-day MA ($671.78) - trend broken

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 57.4% of 52-week range (mid-cycle) - neutral positioning



---

## MSFT

### Phase 2: Combined Data

**Ticker**: MSFT
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $480.84
- Market Cap: $3574.16B
- 52W High: $555.45
- 52W Low: $344.79
- 200D MA: $469.13
- TTM PER: 34.22

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2023 | 9.81 | 34.1% | 43.3 | 15.3 | 14.9 | 28.36 | $64.9B |
| 2024 | 11.82 | 37.1% | 43.5 | 14.2 | 15.6 | 32.82 | $21.6B |
| 2025 | 13.75 | 33.3% | 35.8 | 10.7 | 13.0 | 37.74 | $63.6B |


### Phase 3: Investment Analysis

**Ticker**: MSFT
**Current Price**: $480.84
**Data Period**: 3 years (2023-2025)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $1587.12
- **Logic**: ROE 34.85%, Growth 18.4% → compounding 27.6%, PER 40.9x → 10yr target $6420.77, discounted to $1587.12 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: SELL
- **Target Price**: $252.87
- **PEG Ratio**: 1.86
- **Logic**: EPS growth 18.4% CAGR, PER 34.22 → PEG 1.86

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $119.56
- **Graham Number**: $119.56
- **Logic**: EPS 13.75, BPS 46.21 → Graham # $119.56

#### Ken Fisher (Sales-Based)
- **Verdict**: BUY
- **Target Price**: $546.98
- **Sell Price**: $587.99
- **Logic**: PSR 12.98 vs avg 14.49 → buy target $546.98, max PSR 15.58 → sell at $587.99

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: HOLD
- **Exit Condition**: Exit if price falls below 200-day MA ($469.13)
- **Logic**: Price above 200-day MA but pulled back from 52-week high - trend intact but momentum weak

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 64.6% of 52-week range (mid-cycle) - neutral positioning



---

## NFLX

### Phase 2: Combined Data

**Ticker**: NFLX
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $103.22
- Market Cap: $437.38B
- 52W High: $134.12
- 52W Low: $82.11
- 200D MA: $113.44
- TTM PER: 43.19

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 9.14 | 22.5% | 52.9 | 10.3 | 6.7 | 70.06 | $-0.1B |
| 2023 | 12.03 | 26.1% | 71.3 | 18.0 | 10.9 | 75.02 | $6.7B |
| 2024 | 1.98 | 38.4% | 54.2 | 18.6 | 11.7 | 8.88 | $5.2B |


### Phase 3: Investment Analysis

**Ticker**: NFLX
**Current Price**: $103.22
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: SELL
- **Target Price**: $0.00
- **Logic**: ROE 29.03%, Growth -53.5% → compounding -80.2%, PER 59.5x → 10yr target $0.00, discounted to $0.00 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: N/A
- **Logic**: Growth rate -53.5% too low for Lynch model (minimum 5%)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $16.04
- **Graham Number**: $16.04
- **Logic**: EPS 1.98, BPS 5.77 → Graham # $16.04

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $86.70
- **Sell Price**: $104.07
- **Logic**: PSR 11.72 vs avg 9.76 → buy target $86.70, max PSR 11.72 → sell at $104.07

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: SELL
- **Exit Condition**: Exit if price falls below 200-day MA ($113.44)
- **Logic**: Price $103.22 below 200-day MA ($113.44) - trend broken

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 40.6% of 52-week range (mid-cycle) - neutral positioning



---

## NVDA

### Phase 2: Combined Data

**Ticker**: NVDA
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $183.38
- Market Cap: $4464.75B
- 52W High: $212.19
- 52W Low: $86.62
- 200D MA: $154.31
- TTM PER: 45.39

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2023 | 2.29 | 16.2% | 317.4 | 81.0 | 66.5 | 10.76 | $-1.7B |
| 2024 | 1.22 | 91.5% | 110.6 | 77.1 | 54.0 | 2.44 | $17.5B |
| 2025 | 2.96 | 119.2% | 59.8 | 54.6 | 33.0 | 5.26 | $43.7B |


### Phase 3: Investment Analysis

**Ticker**: NVDA
**Current Price**: $183.38
**Data Period**: 3 years (2023-2025)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $236.86
- **Logic**: ROE 75.61%, Growth 13.7% → compounding 20.5%, PER 162.6x → 10yr target $958.24, discounted to $236.86 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: SELL
- **Target Price**: $40.53
- **PEG Ratio**: 3.32
- **Logic**: EPS growth 13.7% CAGR, PER 45.39 → PEG 3.32

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $14.69
- **Graham Number**: $14.69
- **Logic**: EPS 2.96, BPS 3.24 → Graham # $14.69

#### Ken Fisher (Sales-Based)
- **Verdict**: BUY
- **Target Price**: $269.12
- **Sell Price**: $349.74
- **Logic**: PSR 32.96 vs avg 51.16 → buy target $269.12, max PSR 66.49 → sell at $349.74

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: HOLD
- **Exit Condition**: Exit if price falls below 200-day MA ($154.31)
- **Logic**: Price above 200-day MA but pulled back from 52-week high - trend intact but momentum weak

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 77.1% of 52-week range (mid-cycle) - neutral positioning



---

## TSLA

### Phase 2: Combined Data

**Ticker**: TSLA
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $454.53
- Market Cap: $1511.68B
- 52W High: $488.54
- 52W Low: $214.25
- 200D MA: $341.62
- TTM PER: 317.85

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 3.69 | 33.6% | 57.5 | 15.0 | 8.3 | 23.44 | $2.8B |
| 2023 | 4.30 | 27.9% | 94.5 | 20.7 | 13.5 | 27.77 | $-2.3B |
| 2024 | 2.19 | 10.5% | 196.1 | 19.0 | 14.6 | 27.93 | $-3.9B |


### Phase 3: Investment Analysis

**Ticker**: TSLA
**Current Price**: $454.53
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: SELL
- **Target Price**: $0.40
- **Logic**: ROE 24.02%, Growth -23.0% → compounding -34.4%, PER 116.0x → 10yr target $1.61, discounted to $0.40 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: N/A
- **Logic**: Growth rate -23.0% too low for Lynch model (minimum 5%)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $33.40
- **Graham Number**: $33.40
- **Logic**: EPS 2.19, BPS 22.64 → Graham # $33.40

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $338.98
- **Sell Price**: $408.90
- **Logic**: PSR 14.64 vs avg 12.14 → buy target $338.98, max PSR 14.64 → sell at $408.90

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($341.62)
- **Logic**: Price $454.53 above 200-day MA ($341.62) and near 52-week high ($488.54) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($454.53)
- **Logic**: Price at 87.6% of 52-week range (top) - cycle top risk, consider taking profits



---

## BRK.B

### Phase 2: Combined Data

**Error**: HTTP 500: Internal Server Error

### Phase 3: Investment Analysis

**Error**: HTTP 500: Internal Server Error

---

## JNJ

### Phase 2: Combined Data

**Ticker**: JNJ
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $202.48
- Market Cap: $487.83B
- 52W High: $207.81
- 52W Low: $140.68
- 200D MA: $169.84
- TTM PER: 19.56

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2023 | 8.33 | 18.3% | 17.6 | 5.2 | 4.2 | 33.26 | $21.9B |
| 2024 | 9.99 | 15.7% | 15.7 | 0.0 | 4.4 | 33.26 | $0.0B |
| 2024 | 8.33 | 20.1% | 24.8 | 7.0 | 5.6 | 36.56 | $5.7B |


### Phase 3: Investment Analysis

**Ticker**: JNJ
**Current Price**: $202.48
**Data Period**: 3 years (2023-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: SELL
- **Target Price**: $39.94
- **Logic**: ROE 18.01%, Growth 0.0% → compounding 0.0%, PER 19.4x → 10yr target $161.57, discounted to $39.94 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: N/A
- **Logic**: Growth rate 0.0% too low for Lynch model (minimum 5%)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $74.59
- **Graham Number**: $74.59
- **Logic**: EPS 8.33, BPS 29.69 → Graham # $74.59

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $173.05
- **Sell Price**: $205.10
- **Logic**: PSR 5.61 vs avg 4.73 → buy target $173.05, max PSR 5.61 → sell at $205.10

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($169.84)
- **Logic**: Price $202.48 above 200-day MA ($169.84) and near 52-week high ($207.81) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($202.48)
- **Logic**: Price at 92.1% of 52-week range (top) - cycle top risk, consider taking profits



---

## JPM

### Phase 2: Combined Data

**Ticker**: JPM
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $316.10
- Market Cap: $869.20B
- 52W High: $322.25
- 52W Low: $202.16
- 200D MA: $279.03
- TTM PER: 15.66

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 11.91 | 29.3% | 14.5 | 1.9 | 3.9 | 43.33 | $-30.7B |
| 2023 | 16.85 | 16.9% | 14.2 | 2.3 | 4.3 | 53.72 | $-54.7B |
| 2024 | 18.44 | 18.2% | 17.0 | 2.7 | 4.8 | 61.67 | $-205.4B |


### Phase 3: Investment Analysis

**Ticker**: JPM
**Current Price**: $316.10
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $484.71
- **Logic**: ROE 21.45%, Growth 24.4% → compounding 21.5%, PER 15.2x → 10yr target $1960.92, discounted to $484.71 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: BUY
- **Target Price**: $450.49
- **PEG Ratio**: 0.64
- **Logic**: EPS growth 24.4% CAGR, PER 15.66 → PEG 0.64

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $219.35
- **Graham Number**: $219.35
- **Logic**: EPS 18.44, BPS 115.97 → Graham # $219.35

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $267.03
- **Sell Price**: $299.10
- **Logic**: PSR 4.85 vs avg 4.33 → buy target $267.03, max PSR 4.85 → sell at $299.10

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($279.03)
- **Logic**: Price $316.10 above 200-day MA ($279.03) and near 52-week high ($322.25) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($316.10)
- **Logic**: Price at 94.9% of 52-week range (top) - cycle top risk, consider taking profits



---

## LLY

### Phase 2: Combined Data

**Ticker**: LLY
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $1014.49
- Market Cap: $909.45B
- 52W High: $1111.99
- 52W Low: $623.78
- 200D MA: $810.51
- TTM PER: 49.83

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 8.16 | 21.9% | 81.9 | 59.6 | 22.2 | 31.55 | $3.8B |
| 2023 | 10.07 | 48.9% | 80.6 | 71.5 | 22.6 | 37.78 | $-2.9B |
| 2024 | 16.14 | 84.8% | 66.6 | 71.8 | 22.6 | 49.82 | $-0.5B |


### Phase 3: Investment Analysis

**Ticker**: LLY
**Current Price**: $1014.49
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $5770.00
- **Logic**: ROE 51.88%, Growth 40.6% → compounding 40.0%, PER 76.4x → 10yr target $23342.85, discounted to $5770.00 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: SELL
- **Target Price**: $655.92
- **PEG Ratio**: 1.23
- **Logic**: EPS growth 40.6% CAGR, PER 49.83 → PEG 1.23 (downgraded due to high debt)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $73.76
- **Graham Number**: $73.76
- **Logic**: EPS 16.14, BPS 14.98 → Graham # $73.76

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $1118.29
- **Sell Price**: $1124.44
- **Logic**: PSR 22.57 vs avg 22.45 → buy target $1118.29, max PSR 22.57 → sell at $1124.44

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($810.51)
- **Logic**: Price $1014.49 above 200-day MA ($810.51) and near 52-week high ($1111.99) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($1014.49)
- **Logic**: Price at 80.0% of 52-week range (top) - cycle top risk, consider taking profits



---

## MA

### Phase 2: Combined Data

**Ticker**: MA
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $542.31
- Market Cap: $490.25B
- 52W High: $601.77
- 52W Low: $465.59
- 200D MA: $559.96
- TTM PER: 34.72

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 10.60 | 44.7% | 41.4 | 66.6 | 18.5 | 22.90 | $9.7B |
| 2023 | 12.30 | 169.3% | 43.4 | 71.9 | 19.5 | 26.53 | $10.6B |
| 2024 | 14.68 | 191.9% | 37.5 | 77.6 | 17.6 | 30.39 | $11.4B |


### Phase 3: Investment Analysis

**Ticker**: MA
**Current Price**: $542.31
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $1554.56
- **Logic**: ROE 135.30%, Growth 17.7% → compounding 26.5%, PER 40.8x → 10yr target $6289.05, discounted to $1554.56 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: SELL
- **Target Price**: $259.57
- **PEG Ratio**: 1.96
- **Logic**: EPS growth 17.7% CAGR, PER 34.72 → PEG 1.96 (downgraded due to high debt)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $48.41
- **Graham Number**: $48.41
- **Logic**: EPS 14.68, BPS 7.09 → Graham # $48.41

#### Ken Fisher (Sales-Based)
- **Verdict**: BUY
- **Target Price**: $562.72
- **Sell Price**: $592.91
- **Logic**: PSR 17.55 vs avg 18.52 → buy target $562.72, max PSR 19.51 → sell at $592.91

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: SELL
- **Exit Condition**: Exit if price falls below 200-day MA ($559.96)
- **Logic**: Price $542.31 below 200-day MA ($559.96) - trend broken

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 56.3% of 52-week range (mid-cycle) - neutral positioning



---

## ORCL

### Phase 2: Combined Data

**Ticker**: ORCL
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $214.33
- Market Cap: $611.01B
- 52W High: $345.72
- 52W Low: $118.86
- 200D MA: $211.50
- TTM PER: 49.61

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2023 | 3.30 | 17.0% | 38.1 | 318.4 | 6.9 | 18.06 | $-19.3B |
| 2024 | 4.46 | 83.9% | 48.3 | 28.8 | 10.5 | 20.03 | $11.3B |
| 2025 | 4.43 | 85.4% | 45.6 | 27.7 | 10.0 | 20.03 | $-0.9B |


### Phase 3: Investment Analysis

**Ticker**: ORCL
**Current Price**: $214.33
**Data Period**: 3 years (2023-2025)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $407.43
- **Logic**: ROE 62.08%, Growth 15.9% → compounding 23.8%, PER 44.0x → 10yr target $1648.30, discounted to $407.43 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: SELL
- **Target Price**: $70.27
- **PEG Ratio**: 3.13
- **Logic**: EPS growth 15.9% CAGR, PER 49.61 → PEG 3.13 (downgraded due to high debt)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $26.96
- **Graham Number**: $26.96
- **Logic**: EPS 4.43, BPS 7.29 → Graham # $26.96

#### Ken Fisher (Sales-Based)
- **Verdict**: HOLD
- **Target Price**: $183.41
- **Sell Price**: $210.52
- **Logic**: PSR 10.03 vs avg 9.16 → buy target $183.41, max PSR 10.51 → sell at $210.52

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: HOLD
- **Exit Condition**: Exit if price falls below 200-day MA ($211.50)
- **Logic**: Price above 200-day MA but pulled back from 52-week high - trend intact but momentum weak

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 42.1% of 52-week range (mid-cycle) - neutral positioning



---

## TSM

### Phase 2: Combined Data

**Ticker**: TSM
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $292.93
- Market Cap: $1519.28B
- 52W High: $311.37
- 52W Low: $134.25
- 200D MA: $227.49
- TTM PER: 30.42

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 6.27 | 44.9% | 16.1 | 5.5 | 6.7 | 13.95 | $13.4B |
| 2023 | 7.23 | 30.3% | 30.8 | 8.4 | 10.0 | 17.84 | $10.7B |
| 2024 | 7.24 | 30.3% | 40.4 | 11.1 | 12.9 | 17.84 | $30.7B |


### Phase 3: Investment Analysis

**Ticker**: TSM
**Current Price**: $292.93
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: SELL
- **Target Price**: $150.02
- **Logic**: ROE 35.17%, Growth 7.4% → compounding 11.2%, PER 29.1x → 10yr target $606.92, discounted to $150.02 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: SELL
- **Target Price**: $53.93
- **PEG Ratio**: 4.08
- **Logic**: EPS growth 7.4% CAGR, PER 30.42 → PEG 4.08

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $65.63
- **Graham Number**: $65.63
- **Logic**: EPS 7.24, BPS 26.44 → Graham # $65.63

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $176.46
- **Sell Price**: $230.88
- **Logic**: PSR 12.94 vs avg 9.89 → buy target $176.46, max PSR 12.94 → sell at $230.88

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($227.49)
- **Logic**: Price $292.93 above 200-day MA ($227.49) and near 52-week high ($311.37) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($292.93)
- **Logic**: Price at 89.6% of 52-week range (top) - cycle top risk, consider taking profits



---

## V

### Phase 2: Combined Data

**Ticker**: V
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $327.10
- Market Cap: $634.88B
- 52W High: $375.51
- 52W Low: $299.00
- 200D MA: $345.18
- TTM PER: 32.13

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2023 | 7.20 | 52.9% | 39.1 | 15.4 | 17.1 | 12.99 | $18.7B |
| 2024 | 10.06 | 51.8% | 34.3 | 17.8 | 18.5 | 17.71 | $18.0B |
| 2025 | 11.99 | 52.8% | 27.4 | 17.3 | 16.0 | 20.35 | $22.4B |


### Phase 3: Investment Analysis

**Ticker**: V
**Current Price**: $327.10
**Data Period**: 3 years (2023-2025)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: BUY
- **Target Price**: $2880.45
- **Logic**: ROE 52.48%, Growth 29.0% → compounding 40.0%, PER 33.6x → 10yr target $11653.03, discounted to $2880.45 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: HOLD
- **Target Price**: $348.26
- **PEG Ratio**: 1.11
- **Logic**: EPS growth 29.0% CAGR, PER 32.13 → PEG 1.11

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $71.55
- **Graham Number**: $71.55
- **Logic**: EPS 11.99, BPS 18.98 → Graham # $71.55

#### Ken Fisher (Sales-Based)
- **Verdict**: BUY
- **Target Price**: $349.82
- **Sell Price**: $376.88
- **Logic**: PSR 16.00 vs avg 17.19 → buy target $349.82, max PSR 18.52 → sell at $376.88

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: SELL
- **Exit Condition**: Exit if price falls below 200-day MA ($345.18)
- **Logic**: Price $327.10 below 200-day MA ($345.18) - trend broken

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: HOLD
- **Logic**: Price at 36.7% of 52-week range (mid-cycle) - neutral positioning



---

## WMT

### Phase 2: Combined Data

**Ticker**: WMT
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $114.84
- Market Cap: $915.60B
- 52W High: $114.89
- 52W Low: $79.81
- 200D MA: $98.09
- TTM PER: 40.15

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2023 | 5.27 | 1.9% | 32.3 | 6.0 | 0.8 | 223.59 | $11.1B |
| 2024 | 1.91 | 19.3% | 54.4 | 10.0 | 1.3 | 79.94 | $14.4B |
| 2025 | 2.41 | 22.2% | 46.0 | 9.7 | 1.3 | 84.27 | $15.1B |


### Phase 3: Investment Analysis

**Ticker**: WMT
**Current Price**: $114.84
**Data Period**: 3 years (2023-2025)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: SELL
- **Target Price**: $0.03
- **Logic**: ROE 14.47%, Growth -32.4% → compounding -48.6%, PER 44.2x → 10yr target $0.14, discounted to $0.03 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: N/A
- **Logic**: Growth rate -32.4% too low for Lynch model (minimum 5%)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $24.83
- **Graham Number**: $24.83
- **Logic**: EPS 2.41, BPS 11.37 → Graham # $24.83

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $93.54
- **Sell Price**: $108.71
- **Logic**: PSR 1.29 vs avg 1.11 → buy target $93.54, max PSR 1.29 → sell at $108.71

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($98.09)
- **Logic**: Price $114.84 above 200-day MA ($98.09) and near 52-week high ($114.89) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($114.84)
- **Logic**: Price at 99.9% of 52-week range (top) - cycle top risk, consider taking profits



---

## XOM

### Phase 2: Combined Data

**Ticker**: XOM
**Data Source**: Yahoo_Realtime + Local_JSON_History

**Market Status**:
- Current Price: $117.14
- Market Cap: $499.40B
- 52W High: $120.81
- 52W Low: $97.80
- 200D MA: $110.85
- TTM PER: 17.03

**Financial History** (3 years):

| Year | EPS | ROE | PER | PBR | PSR | SPS | FCF |
|------|-----|-----|-----|-----|-----|-----|-----|
| 2022 | 14.22 | 14.4% | 7.2 | 2.2 | 1.0 | 94.81 | $62.1B |
| 2023 | 9.36 | 18.0% | 11.6 | 2.1 | 1.4 | 82.60 | $36.1B |
| 2024 | 7.86 | 14.4% | 14.7 | 1.9 | 1.4 | 78.93 | $35.1B |


### Phase 3: Investment Analysis

**Ticker**: XOM
**Current Price**: $117.14
**Data Period**: 3 years (2022-2024)

### Investment Verdicts

#### Warren Buffett (Quality & Value)
- **Verdict**: SELL
- **Target Price**: $0.17
- **Logic**: ROE 15.60%, Growth -25.7% → compounding -38.5%, PER 11.2x → 10yr target $0.68, discounted to $0.17 @ 15% return

#### Peter Lynch (Growth at Reasonable Price)
- **Verdict**: N/A
- **Logic**: Growth rate -25.7% too low for Lynch model (minimum 5%)

#### Benjamin Graham (Deep Value)
- **Verdict**: SELL
- **Target Price**: $103.57
- **Graham Number**: $103.57
- **Logic**: EPS 7.86, BPS 60.66 → Graham # $103.57

#### Ken Fisher (Sales-Based)
- **Verdict**: SELL
- **Target Price**: $102.61
- **Sell Price**: $113.66
- **Logic**: PSR 1.44 vs avg 1.30 → buy target $102.61, max PSR 1.44 → sell at $113.66

#### Stanley Druckenmiller (Trend Following)
- **Verdict**: STRONG BUY
- **Exit Condition**: Exit if price falls below 200-day MA ($110.85)
- **Logic**: Price $117.14 above 200-day MA ($110.85) and near 52-week high ($120.81) - strong uptrend

#### Howard Marks (Cycle/Contrarian)
- **Verdict**: WARNING
- **Exit Condition**: Consider partial sell - price at 52-week band top ($117.14)
- **Logic**: Price at 84.1% of 52-week range (top) - cycle top risk, consider taking profits



---

## Summary

- **Total Stocks Tested**: 19
- **Successful**: 18
- **Failed**: 1
- **Success Rate**: 94.7%
